{"schema_version":"secwatch.filing_event.v1","accession":"0001801170-26-000128","form_type":"8-K","ticker":"CLOV","cik":"0001801170","company_name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","filed_at":"2026-05-18T12:32:42+00:00","discovered_at":"2026-05-18T12:35:00.473488+00:00","generated_at":"2026-05-18T12:36:03.502837+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"low","headline":"Clover Health publishes supplemental Q&A for Q1 2026; no specific financial details in filing excerpt","bullets":["Company furnished a supplemental Q&A document responding to shareholder questions about Q1 2026 earnings.","No numerical data, guidance changes, or material updates are present in the provided exhibit excerpt.","CEO Andrew Toy reiterated commitment to transparency and shareholder engagement.","Document is available on the investor relations section of Clover Health's website."],"urls":{"canonical":"https://secwatch.observer/filing/0001801170-26-000128","json":"https://secwatch.observer/filing/0001801170-26-000128.json","markdown":"https://secwatch.observer/filing/0001801170-26-000128.md","text":"https://secwatch.observer/filing/0001801170-26-000128.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1801170/000180117026000128/0001801170-26-000128-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1801170/000180117026000128/clov-20260518.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T12:36:03.502837+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}